Skip to content

Structure and Function of Meibomian Glands in Patients with Abnormal Meibomian Gland Function after Cataract Surgery

Structure and Function of Meibomian Glands in Patients with Abnormal Meibomian Gland Function after Cataract Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048694
Enrollment
Unknown
Registered
2021-07-12
Start date
2020-09-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Function

Interventions

Case series:Before and after cataract surgery

Sponsors

Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50 to 80 years old; 2. Patients who only underwent one-eye cataract surgery in 3 months; 3. with abnormal meibomian gland signs; 4. No subjective symptoms or mild symptoms before surgery (SPEED<=2 points).

Exclusion criteria

Exclusion criteria: 1. Patients who had other ocular diseases, such as eye infections, eye allergies, glaucoma, eye trauma, and autoimmune diseases; 2. Patients who used eye drops for a prolonged period; 3. Patients who had previous ophthalmic surgery history, ocular and systemic diseases related to dry eye; 4. With abnormal anatomical structures such as eyelid, conjunctiva, and cornea, and hence; 5. Patients who had intraoperative and postoperative complications.

Design outcomes

Primary

MeasureTime frame
SPEED questionnaire;TBUT;FL;Eyelid foam;Eyelid hyperemia;Eyelid thickening;meibomian gland opening;Traits of meibum;Meibum secretion;Irregular eyelid;MG dropout grade(upper eyelid);MG dropout grade(lower eyelid);

Countries

China

Contacts

Public ContactJinyang Li

Eye Hospital of Wenzhou Medical University

jinyangli@foxmail.com+86 13957713091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026